کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2473150 | 1555905 | 2016 | 6 صفحه PDF | دانلود رایگان |
• Abundant vasculature could provide access to the CNS but is blocked by the BBB.
• Disruption of BBB tight junctions allows paracellular transport of viral vectors.
• Transient BBB disruption can be global or local.
• Receptor-mediated transcytosis transports viral vectors across the intact BBB.
• Directed evolution can greatly enhance vector transcytosis across BBB.
The abundant vasculature of the CNS provides a compelling route of administration for the delivery of gene therapy vectors if the limitations imposed by the blood–brain-barrier (BBB) can be overcome. There are two general approaches to transporting viral vectors across the BBB: either by transient disruption of brain microvasculature endothelial tight junctions, or through the use of receptor-mediated transcytosis. Advances in BBB disruption have led to pre-clinical success for both global and localized gene delivery, while therapies based on receptor-mediated transcytosis have recently advanced to phase I clinical trials in humans. Both approaches show long term promise for treating a wide range of CNS diseases.
Journal: Current Opinion in Virology - Volume 21, December 2016, Pages 87–92